In 2022, the US Supreme Court overturned Roe v Wade, which guaranteed a constitutional right to an abortion. But previously the Court had allowed restrictions on abortions, making access quite challenging in a large part of the country. In response to these restrictions, women had gained access through prescription drugs, or what is called medication abortion. This involves two prescription drugs, mifepristone and misoprostol. Last week, a federal court issued an order disallowing mifepristone to be prescribed via telehealth and then distributed by mail. As we record today, the Supreme Court is expected to rule on this federal court order. So on today’s show, we take account to the status of access to medication abortion and what it means both for reproductive rights and health and for the law on this issue. [ dur: 58mins. ]
- Rachel Rebouché is Professor of Law at the University of Texas at Austin. She is the author of Abortion Rights as Human Rights and co-author of The New Abortion Battleground and Abortion Pills (with David S. Cohen and Greer Donley).
- Carole Joffe is Professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at the University of California, San Francisco. She is the author of Doctors of Conscience: The Struggle to Provide Abortion before and after Roe v. Wade and the co-author of After Dobbs: How the Supreme Court ended Roe but not Abortion with David Cohen.
- Natalie Fixmer-Oriaz, F Wendell Miller Associate Professor of Communication Studies and Gender, Woman’s the Sexuality Studies at the University of Iowa. She is author of Homeland Maternity: US Security Culture and the New Reproductive Regime (2019) and Doing Gender Justice: Queering Reproduction, Kin, and Care (2025; with Shui-yin Sharon Yam).
This program is produced by Doug Becker, Ankine Aghassian, Maria Armoudian, Anna Lapin and Sudd Dongre.
Health, Medicine, Reproductive Health, Courts, Feminism, Mothers
Podcast: Play in new window | Download
Subscribe: RSS